ARCHIVES

In Brief: David Tweardy named head of internal medicine at MD Anderson

This article is from The Cancer Letter archive.

Vol. 40 No. 35 | September 19, 2014

Download PDF Visit The Full Archive

Related Articles

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

International Group Plans Survey On Thrombosis Risk

July 27, 2001

Includes Sept. Business & Regulatory Report.

September 26, 2003

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

NCI Unveils Checklist for Omics Studies

February 7, 2013